The document discusses Johnson & Johnson's current process for global site budgeting and cost management for clinical trials. The current process aims to provide consistency in approach, fair reimbursement, transparency, and appropriate support for negotiators. It involves developing a global reimbursement range based on fair market value assumptions, collecting county-level cost data, and negotiating site budgets while documenting any exceptions. Challenges include accounting for complex trial procedures, making efficient yet globally comparable budget comparisons, and balancing timelines.